vaccine candidate – Page 38 – Communicable Diseases Research

An overview on COVID-19: reality and expectation

Review

Published on 2020-06-012022-10-28
Journal: Bulletin of the National Research Centre [Category] COVID-19,

[키워드] absence acute respiratory syndrome approved blood pressure Care China Chloroquine clinically comprehensive view coronavirus COVID-19 COVID-19 outbreak detect diabetes Disease diagnosis drug Drug discovery drugs effective emergency situation Favipiravir Herbal treatment Hydroxychloroquine incidence of COVID-19 Infection International Ivermectin Liver disease measure Medical conditions Messenger RNA National obesity other disease Patient Plasma transfusion polymerase chain Prevent progression public health reduce Remdesivir ribavirin risk RT-PCR SARS-CoV-2 Spread susceptible tested treat Treatment Vaccine vaccine candidate Vaccine development Vaccines viral outbreak virus WHO WHO’
[DOI] 10.1186/s42269-020-00341-9 PMC 바로가기 [Article Type] Review

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients

Article

Published on 2020-06-012022-10-04
Journal: Nature Communications [Category] SARS, 진단, 치료기술, 치료법,

[키워드] Alter antibodies antibody B-cell B-cell epitope coronavirus COVID-19 convalescent patients COVID-19 patient diagnostic diagnostics elicit fusion peptide help human antibody response identify IgG immunodominant immunogenic linear linear epitope neutralising neutralising antibody overlapping Patient peptides Receptor binding domain Region SARS-CoV-2 SARS-CoV-2 pandemic SARS-CoV-2 spike glycoprotein SARS-CoV-2 spike protein sera serological test serology significantly spike glycoprotein Spike protein target targets the SARS-CoV-2 vaccine candidate Vaccine development Vaccines viral infection Virus neutralisation
[DOI] 10.1038/s41467-020-16638-2 PMC 바로가기 [Article Type] Article

Towards the design of epitope candidates for Coronavirus 2

Research-Article

Published on 2020-05-312022-10-28
Journal: Bioinformation [Category] COVID-19,

Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV

Research Article

Published on 2020-05-292022-10-31
Journal: Emerging Microbes & Infections [Category] COVID-19, MERS,

Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials

Internal Medicine

Published on 2020-05-282022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] 2019 novel coronavirus Antiviral approved BCG candidate cellular therapy Chinese Chloroquine clinical clinical trial Combination Compound conducted COVID 19 COVID-19 database deaths drug drug combination drug therapeutics effective healthcare ICTRP Infection information lock majority medication novel novel coronavirus disease observational study pandemic Phase I phase III trial registry responsible review sars-cov-2 (severe acute respiratory syndrome coronavirus -2) Stage tested therapeutic agent Therapeutics therapy Treatment treatment choices Trial Vaccine vaccine candidate Vaccines viral infection WHO
[DOI] 10.7759/cureus.8342 PMC 바로가기 [Article Type] Internal Medicine

Immunogenicity of a DNA vaccine candidate for COVID-19

Article

Published on 2020-05-202022-10-04
Journal: Nature Communications [Category] MERS, 치료기술,

Development of an inactivated vaccine candidate for SARS-CoV-2

SARS-CoV-2 불활화백신 후보물질 개발

Report

Published on 2020-05-062022-09-14
Journal: Science (New York, N.y.) [Category] MERS, SARS, 비임상, 진단,

An Erythrocyte Membrane-Associated Antigen, PvTRAg-26 of Plasmodium vivax : A Study of Its Antigenicity and Immunogenicity

말라리아 원충 Plasmodium vivax의 적혈구막 관련 항원 PvTRAg-26: 그 항원성과 면역원성에 대한 연구

Original Research

Published on 2020-04-282024-08-11
Journal: Frontiers in public health [Category] 말라리아,

[키워드] immunogenicity malaria Plasmodium vivax tryptophan-rich antigens vaccine candidate
[DOI] 10.3389/fpubh.2020.00148 PMC 바로가기 [Article Type] Original Research

Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection

중동 호흡기 증후군 코로나바이러스(MERS-CoV) 스파이크 단백질을 발현하는 재조합 파라인플루엔자 바이러스 5를 사용한 단일 용량, 비강내 면역화로 치명적인 MERS-CoV 감염으로부터 마우스 보호

Research Article

Published on 2020-04-072022-09-14
Journal: mBio [Category] 진단, 치료제,

Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review

Review

Published on 2020-02-262022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] 2019 novel coronavirus 2019-nCoV acute respiratory syndrome Antiviral Asia Beijing carried China clinical trial Cochrane Library Compound condition criteria database diagnostics drug combination effective Efficacy Evidence global health Google search identify in vitro Intervention item Laboratory management MERS-CoV Middle East novel Novel coronavirus outbreak Phase 1 point-of-care testing kit polymerase chain Potential protocol Rapid Reporting Research resource reverse transcription review RT-PCR RT-PCR kit SARS-CoV Serological assay supported tested Therapeutics treatments Vaccine vaccine candidate vaccine trial were used
[DOI] 10.3390/jcm9030623 PMC 바로가기 [Article Type] Review